Imperial BRC researchers led by CMBI's Dr Andy Edwards have designed a new way to deliver antibiotics.

Imperial BRC researchers led by CMBI's Dr Andy Edwards have designed a new way to deliver antibiotics that both targets and kills bacteria that have evolved a mechanism of resistance to frontline treatment drugs.  

Since their discovery, antibiotics have become a cornerstone of modern medicine, saving millions of lives. However, excessive and inappropriate use means many antibiotics are rendered ineffective with bacteria evolving to develop resistance, leading to the persistence and potential spread of infections. No new classes of antibiotics have been developed since the 1980’s, creating a pressing need for new drugs or therapeutic delivery.

The full article can be viewed here